Metronomic capecitabine versus doxorubicin in advanced hepatocellular carcinoma

Purpose We evaluated oral metronomic capecitabine (MC) compared to intravenous doxorubicin in patients with advanced or metastatic hepatocellular carcinoma (HCC). Methods From January 2013 to December 2015, patients with Child-Pugh class A or early B were randomized either to MC group (500 mg twice...

Description complète

Détails bibliographiques

Auteurs principaux:	Gehan Abd Elatti Khedr, Sherif Farouk Elzawawy, Ahmad Gaber Gowil, Amany Saleh Elyamany, Mohamed Eshafei
Format:	Artigo
Langue:	Inglês
Publié:	Korean Society of Surgical Oncology 2016-06-01
Collection:	Korean Journal of Clinical Oncology
Sujets:	metronomic capecitabine doxorubicin hepatocellular carcinoma
Accès en ligne:	http://www.kjco.org/upload/kjco-12-1-32.pdf
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!